CVE:IGP - Imperial Ginseng Products Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
C$1.65 +0.02 (+1.23 %)
(As of 05/22/2018 01:51 AM ET)
Previous CloseC$1.65
Today's RangeC$1.65 - C$1.65
52-Week RangeC$0.82 - C$2.00
Volume1,700 shs
Average Volume3,690 shs
Market CapitalizationC$12.62 million
P/E RatioN/A
Dividend YieldN/A

About Imperial Ginseng Products (CVE:IGP)

Imperial Ginseng Products Ltd. engages in cultivating and processing ginseng in the province of Ontario. It is also involved in the sale of dried ginseng to wholesalers in Asia and North America. The company was founded in 1989 and is headquartered in Vancouver, Canada.

Receive IGP News and Ratings via Email

Sign-up to receive the latest news and ratings for IGP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Farm Products
SectorConsumer Goods


Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A


EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on Equity18.40%
Return on Assets13.99%


Outstanding Shares7,210,000

Imperial Ginseng Products (CVE:IGP) Frequently Asked Questions

What is Imperial Ginseng Products' stock symbol?

Imperial Ginseng Products trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IGP."

How were Imperial Ginseng Products' earnings last quarter?

Imperial Ginseng Products Ltd. (CVE:IGP) issued its quarterly earnings data on Monday, February, 26th. The company reported $0.19 earnings per share for the quarter. The company had revenue of $1.85 million for the quarter. View Imperial Ginseng Products' Earnings History.

When is Imperial Ginseng Products' next earnings date?

Imperial Ginseng Products is scheduled to release their next quarterly earnings announcement on Wednesday, September, 12th 2018. View Earnings Estimates for Imperial Ginseng Products.

Who are some of Imperial Ginseng Products' key competitors?

Who are Imperial Ginseng Products' key executives?

Imperial Ginseng Products' management team includes the folowing people:
  • Mr. Stephen P. McCoach CA, CPA, Co-Chairman, CEO & Sec. (Age 59)
  • Mr. Hugh Robert Cartwright B.Comm, Co-Chairman & Pres (Age 55)
  • Ms. Amelia Yeo, Chief Financial Officer (Age 53)
  • Mr. Maurice A. Levesque, Exec. VP & Exec. Director (Age 59)
  • Mr. Michael Peever, Pres of Canadian Imperial Ginseng Ontario Ltd

Has Imperial Ginseng Products been receiving favorable news coverage?

Headlines about IGP stock have been trending somewhat positive on Tuesday, according to Accern. Accern identifies negative and positive media coverage by reviewing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Imperial Ginseng Products earned a media sentiment score of 0.17 on Accern's scale. They also assigned news articles about the company an impact score of 47.37 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

How do I buy shares of Imperial Ginseng Products?

Shares of IGP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Imperial Ginseng Products' stock price today?

One share of IGP stock can currently be purchased for approximately C$1.65.

How big of a company is Imperial Ginseng Products?

Imperial Ginseng Products has a market capitalization of C$12.62 million.

How can I contact Imperial Ginseng Products?

Imperial Ginseng Products' mailing address is Suite 3030 650 West Georgia Street, VANCOUVER, BC V6B 4N7, Canada. The company can be reached via phone at +1-604-6898863.

MarketBeat Community Rating for Imperial Ginseng Products (IGP)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  22 (Vote Outperform)
Underperform Votes:  34 (Vote Underperform)
Total Votes:  56
MarketBeat's community ratings are surveys of what our community members think about Imperial Ginseng Products and other stocks. Vote "Outperform" if you believe IGP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IGP will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Imperial Ginseng Products (CVE:IGP) Analyst Ratings History

DateBrokerageActionRatingPrice TargetDetails
(Data available from 5/22/2016 forward)


Imperial Ginseng Products (CVE:IGP) Earnings History and Estimates Chart

Earnings by Quarter for Imperial Ginseng Products (CVE:IGP)

Imperial Ginseng Products (CVE IGP) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/26/2018Q2 2018C$0.19C$1.85 millionViewN/AView Earnings Details
11/23/2017Q1 2018C$0.02ViewN/AView Earnings Details
9/13/2017Q4 2017C$0.17C$0.89 millionViewN/AView Earnings Details
5/26/2017Q3 2017C$0.08C$1.07 millionViewN/AView Earnings Details
2/24/2017Q2 2017C$0.39C$8.30 millionViewN/AView Earnings Details
11/25/2016Q1 2017C$0.01C$1.72 millionViewN/AView Earnings Details
9/22/2016Q4 2016C($0.28)C$1.57 millionViewN/AView Earnings Details
5/26/2016Q3 2016C$0.06C$0.85 millionViewN/AView Earnings Details
2/24/2016Q2 2016C$0.35C$5.09 millionViewN/AView Earnings Details
11/26/2015Q1 2016C$0.05ViewN/AView Earnings Details
5/29/2015Q3 2015C$0.14C$1.56 millionViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)


Imperial Ginseng Products (CVE:IGP) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Imperial Ginseng Products (CVE IGP) Insider Trading and Institutional Ownership History

Insider Trading History for Imperial Ginseng Products (CVE:IGP)

Imperial Ginseng Products (CVE IGP) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/7/2018James ChangInsiderSell3,000C$1.70C$5,100.00
2/5/2018James ChangInsiderSell1,700C$1.70C$2,890.00
1/22/2018James ChangInsiderSell1,900C$1.60C$3,040.00
1/18/2018James ChangInsiderSell5,500C$1.60C$8,800.00
1/15/2018James ChangInsiderSell600C$1.55C$930.00
1/12/2018James ChangInsiderSell9,400C$1.55C$14,570.00
11/27/2017James ChangInsiderSell6,600C$1.60C$10,560.00
11/17/2017James ChangInsiderSell3,400C$1.60C$5,440.00
11/8/2017James ChangInsiderSell10,000C$1.60C$16,000.00
11/6/2017James ChangInsiderSell4,000C$1.55C$6,200.00
10/6/2017Robert Hugh CartwrightInsiderSell2,000C$1.50C$3,000.00
10/5/2017Robert Hugh CartwrightInsiderSell3,000C$0.50C$1,500.00
9/14/2017James ChangInsiderSell4,000C$1.10C$4,400.00
9/13/2017James ChangInsiderSell5,000C$1.10C$5,500.00
6/22/2017James ChangInsiderSell1,500C$1.00C$1,500.00
4/3/2017Robert Hugh CartwrightInsiderBuy10,000C$0.75C$7,500.00
3/8/2017Robert Hugh CartwrightInsiderSell6,500C$0.66C$4,290.00
11/27/2015James ChangDirectorSell1,781C$0.65C$1,157.65
11/26/2015James ChangDirectorSell7,000C$0.65C$4,550.00
(Data available from 1/1/2013 forward)


Imperial Ginseng Products (CVE IGP) News Headlines

Imperial Ginseng Products (IGP) Insider James Chang Sells 9,400 SharesImperial Ginseng Products (IGP) Insider James Chang Sells 9,400 Shares - January 19 at 4:46 PM
Imperial Ginseng Products Ltd. (IGP) Insider James Chang Sells 6,600 SharesImperial Ginseng Products Ltd. (IGP) Insider James Chang Sells 6,600 Shares - November 28 at 2:26 PM

SEC Filings

Imperial Ginseng Products (CVE:IGP) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media


Financials are not available for this stock.


Imperial Ginseng Products (CVE IGP) Stock Chart for Tuesday, May, 22, 2018

Loading chart…

This page was last updated on 5/22/2018 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.